154 related articles for article (PubMed ID: 22544014)
41. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.
Colvin L; Slack-Smith L; Stanley FJ; Bower C
CNS Drugs; 2012 Jul; 26(7):e1-14. PubMed ID: 22712699
[TBL] [Abstract][Full Text] [Related]
42. Antidepressant use and risk of adverse outcomes in people aged 20-64 years: cohort study using a primary care database.
Coupland C; Hill T; Morriss R; Moore M; Arthur A; Hippisley-Cox J
BMC Med; 2018 Mar; 16(1):36. PubMed ID: 29514662
[TBL] [Abstract][Full Text] [Related]
43. Association between haemorrhages and treatment with selective and non-selective serotonergic antidepressants: Possible implications of quantitative signal detection.
Gahr M; Zeiss R; Lang D; Connemann BJ; Hiemke C; Muche R; Freudenmann RW; Schönfeldt-Lecuona C
Psychiatry Res; 2015 Sep; 229(1-2):257-63. PubMed ID: 26208982
[TBL] [Abstract][Full Text] [Related]
44. Use of Selective Serotonin Reuptake Inhibitors and Risk of Hip Fracture in the Elderly: A Case-Control Study in Taiwan.
Hung SC; Lin CH; Hung HC; Lin CL; Lai SW
J Am Med Dir Assoc; 2017 Apr; 18(4):350-354. PubMed ID: 28159466
[TBL] [Abstract][Full Text] [Related]
45. Selective serotonin reuptake inhibitors during pregnancy Do not increase the risk of Hirschsprung disease.
Granström AL; Skoglund C; Wester T
J Pediatr Surg; 2019 Nov; 54(11):2398-2401. PubMed ID: 30867098
[TBL] [Abstract][Full Text] [Related]
46. Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction.
Meier CR; Schlienger RG; Jick H
Br J Clin Pharmacol; 2001 Aug; 52(2):179-84. PubMed ID: 11488775
[TBL] [Abstract][Full Text] [Related]
47. Selective Serotonin Reuptake Inhibitors and Risk of Noncardioembolic Ischemic Stroke: A Nested Case-Control Study.
Alqdwah-Fattouh R; Rodríguez-Martín S; Barreira-Hernández D; Izquierdo-Esteban L; Gil M; González-Bermejo D; Fernández-Antón E; Rodríguez-Miguel A; García-Lledó A; Bolúmar F; de Abajo FJ
Stroke; 2022 May; 53(5):1560-1569. PubMed ID: 35109681
[TBL] [Abstract][Full Text] [Related]
48. Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents.
Sun JW; Hernández-Díaz S; Haneuse S; Bourgeois FT; Vine SM; Olfson M; Bateman BT; Huybrechts KF
JAMA Psychiatry; 2021 Jan; 78(1):91-100. PubMed ID: 32876659
[TBL] [Abstract][Full Text] [Related]
49. Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: A study from The Norwegian Mother and Child Cohort Study.
Lupattelli A; Wood M; Lapane K; Spigset O; Nordeng H
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1266-1276. PubMed ID: 28815791
[TBL] [Abstract][Full Text] [Related]
50. Antidepressants and the risk of suicidal behaviors.
Jick H; Kaye JA; Jick SS
JAMA; 2004 Jul; 292(3):338-43. PubMed ID: 15265848
[TBL] [Abstract][Full Text] [Related]
51. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
[TBL] [Abstract][Full Text] [Related]
52. Use of selective serotonin reuptake inhibitors and outcomes in pulmonary arterial hypertension.
Sadoughi A; Roberts KE; Preston IR; Lai GP; McCollister DH; Farber HW; Hill NS
Chest; 2013 Aug; 144(2):531-541. PubMed ID: 23558791
[TBL] [Abstract][Full Text] [Related]
53. A population-based case-control study of Selective Serotonin Reuptake Inhibitors (SSRIs) and breast cancer: the impact of duration of use, cumulative dose and latency.
Ashbury JE; Lévesque LE; Beck PA; Aronson KJ
BMC Med; 2010 Dec; 8():90. PubMed ID: 21176215
[TBL] [Abstract][Full Text] [Related]
54. Selective serotonin reuptake inhibitors use and hepatocellular carcinoma in patients with alcohol use disorder.
Chen VC; Lee MJ; Yang YH; Lu ML; Chiu WC; Dewey ME
Drug Alcohol Depend; 2021 Feb; 219():108495. PubMed ID: 33429293
[TBL] [Abstract][Full Text] [Related]
55. Use of selective serotonin reuptake inhibitors antidepressants and bleeding risk in breast cosmetic surgery.
Basile FV; Basile AR; Basile VV
Aesthetic Plast Surg; 2013 Jun; 37(3):561-6. PubMed ID: 23571783
[TBL] [Abstract][Full Text] [Related]
56. Selective Serotonin Reuptake Inhibitors and Violent Crime: A Cohort Study.
Molero Y; Lichtenstein P; Zetterqvist J; Gumpert CH; Fazel S
PLoS Med; 2015 Sep; 12(9):e1001875. PubMed ID: 26372359
[TBL] [Abstract][Full Text] [Related]
57. Kidney function and prescribed dose in middle-aged and older patients starting selective serotonin reuptake inhibitors.
Zhu N; Lisinski A; Lagerberg T; Johnell K; Xu H; Carrero JJ; Chang Z
Pharmacoepidemiol Drug Saf; 2022 Oct; 31(10):1091-1101. PubMed ID: 36076345
[TBL] [Abstract][Full Text] [Related]
58. Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality.
Stephansson O; Kieler H; Haglund B; Artama M; Engeland A; Furu K; Gissler M; Nørgaard M; Nielsen RB; Zoega H; Valdimarsdóttir U
JAMA; 2013 Jan; 309(1):48-54. PubMed ID: 23280224
[TBL] [Abstract][Full Text] [Related]
59. Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitors: data from the World Health Organization (WHO) database of adverse drug reactions.
Spigset O; Hägg S; Bate A
Int Clin Psychopharmacol; 2003 May; 18(3):157-61. PubMed ID: 12702895
[TBL] [Abstract][Full Text] [Related]
60. Differences in Associations of Antidepressants and Hospitalization Due to Hyponatremia.
Farmand S; Lindh JD; Calissendorff J; Skov J; Falhammar H; Nathanson D; Mannheimer B
Am J Med; 2018 Jan; 131(1):56-63. PubMed ID: 28803926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
